| Website image | URL of site archived | Date archived |
Archive type |
 | https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/safety-covid-19-vaccines | Tue, 13 Jun 2023 14:03:54 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/news/ema-ecdc-statement-updating-covid-19-vaccines-target-new-sars-cov-2-virus-variants | Tue, 13 Jun 2023 13:40:42 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax#safety-updates-section | Mon, 10 Jan 2022 23:34:40 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax | Mon, 10 Jan 2022 22:59:37 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#safety-updates-section | Tue, 26 Oct 2021 04:28:08 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters | Tue, 26 Oct 2021 04:23:04 GMT
| Archived webpage |
 | https://www.ema.europa.eu/en/news/ema-advises-against-use-ivermectin-prevention-treatment-covid-19-outside-randomised-clinical-trials | Tue, 19 Oct 2021 21:48:51 GMT
| Archived webpage |
